Viewing Study NCT01044069

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-01-01 @ 6:59 PM
Study NCT ID: NCT01044069
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2010-01-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cyclophosphamide View
None T cell View
None leukapheresis View
None stem cell transplant View
None bone marrow transplant View
None 09-114 View